Phase II trial of sorafenib combined with on-demand transarterial chemoembolization for advanced stage hepatocellular carcinoma (Barcelona Clinic Liver Cancer stage C): STAB study. Survival according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback